Kopran (KOPRAN) Share Price Falls 8.55%: What Changed Today
- October 8, 2026
- Posted by: Kunal Singla
- Category: News
Kopran Share Price moved lower today, with Kopran Share Price at Rs 252.8 after an 8.55% decline from the previous close of Rs 276.45. The company’s market capitalisation stood at Rs 1,304.56 crore, placing it in the Small Cap category. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. That makes Kopran Share Price news a market-watch event built primarily around the trading move, valuation context and sector positioning rather than a fresh business update. For readers tracking Kopran Share Price Today, the key question is less about a stated trigger and more about how the fall fits with the stock’s current multiples, profitability ratios and comparison with healthcare peers.
Kopran (KOPRAN) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 252.8 |
| Previous Close | Rs 276.45 |
| Today's Move | -Rs 23.65 (-8.55%) |
| Open | Rs 280.55 |
| High | Rs 280.55 |
| Low | Rs 251.05 |
| Market Capitalisation | Rs 1,304.56 crore |
| Market Cap Category | Small Cap |
Kopran Share Price opened at Rs 280.55, touched a high of Rs 280.55 and a low of Rs 251.05, before last trading at Rs 252.8. The stock was down Rs 23.65, or 8.55%, versus the previous close of Rs 276.45. That leaves Kopran Share Price closer to the day’s low than the day’s open, which is important context for anyone tracking Kopran Share Price Today or following Kopran Stock News. The intraday move also widened the gap between the opening level and the latest trade, while the market capitalisation remained Rs 1,304.56 crore. In simple terms, Kopran Share Price reflected a sharp same-day decline inside the Small Cap bracket, and the price action itself now becomes the starting point for Kopran Share Price analysis rather than the end of the discussion. The session opened well above the final trade, and the stock spent the day moving back toward the lower end of the range. For market readers, that sequence matters because Kopran Share Price did not just close lower; it also weakened from the opening level during the same session.
The latest move also gives a clean reference point for short-term tracking. With the day’s high matching the open and the low sitting just above the final price, Kopran Share Price showed a narrow finish relative to the full intraday range. That makes the closing level useful for anyone comparing the latest trade with the previous close and the session extremes. For Kopran Share Price Today, the key takeaway is the size of the decline and the fact that no separate business announcement has been identified in the provided data.
Kopran (KOPRAN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,304.56 crore |
| P/E Ratio | 53.47x |
| P/B Ratio | 2.49x |
| ROE | 4.92% |
| ROCE | 6.65% |
| EPS | Rs 5.17 |
| Book Value Per Share | Rs 110.98 |
| Dividend Yield | 1.09% |
Kopran (KOPRAN) fundamental metrics show P/E 53.47x, P/B 2.49x, ROE 4.92%, ROCE 6.65%. These figures provide context only and are not a buy or sell signal.
Kopran has a market capitalisation of Rs 1,304.56 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 53.47x, P/B at 2.49x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 4.92% and ROCE of 6.65%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 5.17, book value per share of Rs 110.98, dividend yield of 1.09%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.87x, median ROE of 11.61%, median ROCE of 13.46%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 53.47x |
| Benchmark Median P/E | 31.87x |
| Benchmark Average P/E | 48.48x |
| Benchmark P/E Range | 3.58x to 708.87x |
| Company P/B Ratio | 2.49x |
| Benchmark Median P/B | 2.98x |
| Benchmark Average P/B | 4.31x |
| Company ROE | 4.92% |
| Benchmark Median ROE | 11.61% |
| Benchmark Average ROE | 10.59% |
| Company ROCE | 6.65% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 13.36% |
| Company Market Capitalisation | Rs 1,304.56 crore |
| Benchmark Median Market Cap | Rs 854.81 crore |
| Benchmark Average Market Cap | Rs 14,121.7 crore |
Kopran (KOPRAN) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Kopran (KOPRAN) has a P/E ratio of 53.47x, which is above the benchmark median of 31.87x, a difference of +67.78%. On its own, the P/E gap is a valuation reference point, not a trading call.
Kopran (KOPRAN) has a ROE of 4.92%, which is below the benchmark median of 11.61%, a difference of -57.62%. Kopran (KOPRAN) has a ROCE of 6.65%, which is below the benchmark median of 13.46%, a difference of -50.59%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,32,120.23 | 35.37 | 4.95 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,53,389.76 | 86.95 | 14.4 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,81,739.76 | 82.14 | 19.96 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,15,710.44 | 25.51 | 4.27 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,10,980.13 | 101.55 | 19.69 | 18.31 | 18.2 |
Kopran (KOPRAN) has a P/E ratio of 53.47x compared with the displayed peer median of 82.14x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 4.92% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 6.65% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Kopran (KOPRAN) has a market capitalisation of Rs 1,304.56 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Kopran
- Kopran Share Price fell 8.55% in the latest session, making today’s decline the main market event.
- The stock traded between Rs 251.05 and Rs 280.55, giving a clear intraday range for Kopran Share Price Today.
- Kopran Share Price carries a P/E of 53.47, which is above the same-industry median.
- ROE of 4.92% and ROCE of 6.65% keep the Kopran Fundamental Analysis in focus.
- Kopran Share Price also trades with a market cap of Rs 1,304.56 crore in the Small Cap category.
About Kopran
Kopran operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s business context places it within a large industry universe where valuation and returns vary widely across listed names. For Kopran Share Price readers, the most relevant company-level facts today are its Small Cap status, its market capitalisation of Rs 1,304.56 crore, and its profit-return metrics. Kopran Share Price news is therefore best understood as a mix of business classification, valuation and relative scale, rather than through any unverified operating catalyst. The company’s EPS, book value and dividend yield help anchor the share price discussion in reported per-share economics. These details are enough to frame the stock without adding assumptions about what caused the move. Kopran Share Price remains the central reference point for anyone following the session.
Track Kopran Share Price on Univest
Use Kopran (KOPRAN) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Kopran Share Price on Univest for live price updates, fundamental ratios, 52-week levels and market insights in one place. Univest brings together Kopran Share Price Today, Kopran Stock News, valuation metrics, and sector context so readers can follow the stock’s movement alongside its peer and industry view. That makes the page useful for quick checks during the session and for later comparison with the same industry set.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
What is Kopran Share Price today?
Ans. Kopran Share Price was Rs 252.8 in the latest trade, down 8.55% from the previous close of Rs 276.45. The stock also traded between Rs 251.05 and Rs 280.55 during the session.
Why did Kopran Share Price fall today?
Ans. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. Kopran Share Price moved lower on the day, while the broader discussion remains centered on price action and valuation.
What is Kopran Share Price market capitalisation?
Ans. Kopran Share Price corresponds to a market capitalisation of Rs 1,304.56 crore. That places the company in the Small Cap category and above the same-industry market-cap median of Rs 854.81 crore.
What does Kopran fundamental analysis show?
Ans. Kopran Fundamental Analysis shows a P/E of 53.47, P/B of 2.49, ROE of 4.92% and ROCE of 6.65%. EPS is Rs 5.17, book value is Rs 110.98 and dividend yield is 1.09%.
How does Kopran Share Price compare with sector benchmarks?
Ans. Kopran Share Price trades at a P/E above the same-industry median of 31.87 and a P/B below the median of 2.98. Its ROE and ROCE are also below the industry medians.
Is Kopran Share Price expensive versus peers?
Ans. Kopran Share Price is not the highest-valued healthcare name in the peer set, but its P/E of 53.47 is above Sun Pharmaceutical Industries and below some larger pharma peers. Return ratios remain weaker.
What were Kopran Share Price open, high and low levels?
Ans. Kopran Share Price opened at Rs 280.55, touched a high of Rs 280.55 and a low of Rs 251.05. The latest trade stood at Rs 252.8, close to the lower end of the day’s range.
How does Kopran compare with other healthcare stocks?
Ans. Kopran Share Price sits below peers such as Sun Pharmaceutical Industries, Divi’s Laboratories and Torrent Pharmaceuticals on size and profitability, while Zydus Lifesciences shows stronger return metrics. Comparable listed companies include Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals.
Should investors track Kopran Share Price on Univest?
Ans. Yes, readers tracking Kopran Share Price Today can use Univest for live price updates, valuation ratios, 52-week levels and sector context. The platform also keeps Kopran Stock News and company metrics in one place.
